Search
for
Sort by
Research 421–450 of 1000+
- An explorative study of the encoding/decoding model in respect to television news in Papua New Guinea
- Finasteride Doesn't Shorten Survival in Long-term Study
- ILDS Newsletter No. 29
- A Slippery Preventive Slope
- Follow-Up of 1 mg Finasteride Treatment of Male Pattern Baldness—Difference between Clinical Trials and Private Office Follow-Up
- Neurosteroids as Endogenous Regulators of Seizure Susceptibility
- Hair Drug Testing Routine in Many Clinical and Forensic Applications
- Book Reviews
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Geographical Differences in Male Infertility between the United States and Canada: Insights from the Andrology Research Consortium
- Major randomized clinical studies of alopecia treatment with platelet-rich plasma: a systematic review
- SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
- 017 Pharmacovigilance Analysis of Reports of Sexual Dysfunction Associated with Finasteride Use: Implications for the Post-Finasteride Syndrome
- 222 Pharmacovigilance Analysis of Reports of Sexual Dysfunction Associated with Finasteride Use: Implications for the Post-Finasteride Syndrome
- Nailfold capillaroscopy alterations in androgenetic alopecia: A cross-sectional study
- En pacientes jóvenes, el uso de finasteride podría asociarse con mayor riesgo de ansiedad, depresión y eventos adversos relacionados con el suicidio
- 072 Covid-19 and male androgenetic alopecia: Systematic investigation of a potential epidemiological and genetic association
- Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System.
- Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System.
- Post-Finasteride Syndrome – When will we Get the Courage to Fight the Dictating Pharma Industry – Despite Awareness of “Sexual, Neurological and Metabolic Side Effects in Young Men for Over a Decade”
- Supplementary Material for: Polymorphic CAG Repeat Numbers in the Androgen Receptor Gene of Female Pattern Hair Loss in a Han Chinese Population
- Interventions for female pattern hair loss
- Drug-Induced Skin, Nail and Hair Disorders
- Medical comorbidities in patients with lichen planopilaris, a retrospective case–control study
- Body Hair Transplant by Follicular Unit Extraction: My Experience With 122 Patients
- Efficacy of stem cell therapy for burn wounds: a systematic review and meta-analysis of preclinical studies
- Cross-sex hormone therapy in Australia: the prescription patterns of clinicians experienced in adult transgender healthcare
- Prevalence and Factors Associated with Neonatal Occipital Alopecia: A Retrospective Study
- A surge in the incidence of telogen effluvium in minority predominant communities heavily impacted by COVID-19
- A Critical Review on Obstetric Follow-up of Women Affected by Systemic Lupus Erythematosus